Molecular Partners (MOLN) Projected to Post Earnings on Thursday

Molecular Partners (NASDAQ:MOLN) is anticipated to post its quarterly earnings results after the market closes on Thursday, March 6th. Analysts expect Molecular Partners to post earnings of ($0.45) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Molecular Partners Trading Down 7.0 %

NASDAQ:MOLN opened at $4.68 on Wednesday. The firm has a market cap of $188.90 million, a price-to-earnings ratio of -2.18 and a beta of 1.06. The company’s 50-day moving average is $5.13 and its two-hundred day moving average is $5.39. Molecular Partners has a 12-month low of $3.32 and a 12-month high of $12.70.

Molecular Partners Company Profile

Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The company develops MP0317, a CD40 agonist designed to activate immune cells within the tumor microenvironment by anchoring to fibroblast activation protein that is in Phase I clinical trial; and MP0533, a novel tetra-specific T cell-engaging DARPin for acute myeloid leukemia.